Integration of Model I and Model II resulted in a comprehensive CRC prognosis model comprising six MSI-related genes (GNL3, VSIR, LY86, ARHGAP25, DERL3, JAML) and two clinical features (M and stage). The gene discussed is LY86; the disease is colorectal carcinoma.